Makiko Omi

11PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisSurgeryApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 09, 2026
Prevalence and clinicopathologic features of mismatch repair-deficient endometrial cancer in Japanese patients younger than 50 years: a single-center prospective observational study.

Hidetaka Nomura, Akiko Abe, Atsushi Fusegi

|Mar 30, 2026
Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer.

Yusuke Toyohara, Mayu Yunokawa, Ryo Nimura

|Jan 28, 2026
Surgical Timing and Survival in Advanced High-Grade Serous Ovarian Cancer in the PARP Inhibitor Era.

Motoko Kanno, Atsushi Fusegi, Naoki Miyazaki

|Jan 27, 2026
Case report on critical well-leg compartment syndrome: early diagnosis and treatment after cervical cancer surgery.

Makiko Omi, Masanori Saito, Shogo Nishino

|Dec 06, 2024
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience.

Mayu Yunokawa, Akiko Abe, Xiaofei Wang

|Oct 14, 2024
Secondary spontaneous pneumothorax during chemotherapy with bevacizumab for cervical cancer: a case report and literature review.

Shogo Nishino, Mayu Yunokawa, Yosuke Matsuura

Pageof 2

Frequent Collaborators

10 joint publications

Hiroyuki Kanao

8 joint publications

Atsushi Fusegi

8 joint publications

Mayu Yunokawa

7 joint publications

Hidetaka Nomura